Articles published by MacroGenics, Inc.
    MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
    
   September 02, 2025
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
   
    MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
    
   June 10, 2025
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
    
   June 03, 2025
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
    
   March 06, 2025
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conferences
    
   February 27, 2025
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conference
    
   December 02, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conferences
    
   November 06, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics Announces Leadership Transition
    
   October 30, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics Provides Vobramitamab Duocarmazine Update
    
   July 30, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
    
   April 03, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conferences
    
   March 01, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
    
   February 27, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conference
    
   February 02, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conference
    
   January 08, 2024
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conferences
    
   November 02, 2023
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
    
   September 05, 2023
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   
    MacroGenics to Participate in Upcoming Investor Conferences
    
   August 31, 2023
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
    
   From MacroGenics, Inc.
   Via GlobeNewswire
    Tickers
      MGNX
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.